These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Trimeric G protein-CARMA1 axis links smoothened, the hedgehog receptor transducer, to NF-κB activation in diffuse large B-cell lymphoma. Qu C; Liu Y; Kunkalla K; Singh RR; Blonska M; Lin X; Agarwal NK; Vega F Blood; 2013 Jun; 121(23):4718-28. PubMed ID: 23632891 [TBL] [Abstract][Full Text] [Related]
5. MALT1 Phosphorylation Controls Activation of T Lymphocytes and Survival of ABC-DLBCL Tumor Cells. Gehring T; Erdmann T; Rahm M; Graß C; Flatley A; O'Neill TJ; Woods S; Meininger I; Karayel O; Kutzner K; Grau M; Shinohara H; Lammens K; Feederle R; Hauck SM; Lenz G; Krappmann D Cell Rep; 2019 Oct; 29(4):873-888.e10. PubMed ID: 31644910 [TBL] [Abstract][Full Text] [Related]
6. Protein kinase C-δ negatively regulates T cell receptor-induced NF-κB activation by inhibiting the assembly of CARMA1 signalosome. Liu Y; Song R; Gao Y; Li Y; Wang S; Liu HY; Wang Y; Hu YH; Shu HB J Biol Chem; 2012 Jun; 287(24):20081-7. PubMed ID: 22528498 [TBL] [Abstract][Full Text] [Related]
7. Molecular Determinants of Scaffold-induced Linear Ubiquitinylation of B Cell Lymphoma/Leukemia 10 (Bcl10) during T Cell Receptor and Oncogenic Caspase Recruitment Domain-containing Protein 11 (CARD11) Signaling. Yang YK; Yang C; Chan W; Wang Z; Deibel KE; Pomerantz JL J Biol Chem; 2016 Dec; 291(50):25921-25936. PubMed ID: 27777308 [TBL] [Abstract][Full Text] [Related]
8. The Ca2+-dependent phosphatase calcineurin controls the formation of the Carma1-Bcl10-Malt1 complex during T cell receptor-induced NF-kappaB activation. Palkowitsch L; Marienfeld U; Brunner C; Eitelhuber A; Krappmann D; Marienfeld RB J Biol Chem; 2011 Mar; 286(9):7522-34. PubMed ID: 21199863 [TBL] [Abstract][Full Text] [Related]
9. A quantitative signaling screen identifies CARD11 mutations in the CARD and LATCH domains that induce Bcl10 ubiquitination and human lymphoma cell survival. Chan W; Schaffer TB; Pomerantz JL Mol Cell Biol; 2013 Jan; 33(2):429-43. PubMed ID: 23149938 [TBL] [Abstract][Full Text] [Related]
10. Role of the CARMA1/BCL10/MALT1 complex in lymphoid malignancies. Juilland M; Thome M Curr Opin Hematol; 2016 Jul; 23(4):402-9. PubMed ID: 27135977 [TBL] [Abstract][Full Text] [Related]
11. The protein kinase C-responsive inhibitory domain of CARD11 functions in NF-kappaB activation to regulate the association of multiple signaling cofactors that differentially depend on Bcl10 and MALT1 for association. McCully RR; Pomerantz JL Mol Cell Biol; 2008 Sep; 28(18):5668-86. PubMed ID: 18625728 [TBL] [Abstract][Full Text] [Related]
12. Targeting Non-proteolytic Protein Ubiquitination for the Treatment of Diffuse Large B Cell Lymphoma. Yang Y; Kelly P; Shaffer AL; Schmitz R; Yoo HM; Liu X; Huang DW; Webster D; Young RM; Nakagawa M; Ceribelli M; Wright GW; Yang Y; Zhao H; Yu X; Xu W; Chan WC; Jaffe ES; Gascoyne RD; Campo E; Rosenwald A; Ott G; Delabie J; Rimsza L; Staudt LM Cancer Cell; 2016 Apr; 29(4):494-507. PubMed ID: 27070702 [TBL] [Abstract][Full Text] [Related]
13. Oncogenic CARMA1 couples NF-κB and β-catenin signaling in diffuse large B-cell lymphomas. Bognar MK; Vincendeau M; Erdmann T; Seeholzer T; Grau M; Linnemann JR; Ruland J; Scheel CH; Lenz P; Ott G; Lenz G; Hauck SM; Krappmann D Oncogene; 2016 Aug; 35(32):4269-81. PubMed ID: 26776161 [TBL] [Abstract][Full Text] [Related]
14. AIP augments CARMA1-BCL10-MALT1 complex formation to facilitate NF-κB signaling upon T cell activation. Schimmack G; Eitelhuber AC; Vincendeau M; Demski K; Shinohara H; Kurosaki T; Krappmann D Cell Commun Signal; 2014 Jul; 12():49. PubMed ID: 25245034 [TBL] [Abstract][Full Text] [Related]
16. MALT1/paracaspase is a signaling component downstream of CARMA1 and mediates T cell receptor-induced NF-kappaB activation. Che T; You Y; Wang D; Tanner MJ; Dixit VM; Lin X J Biol Chem; 2004 Apr; 279(16):15870-6. PubMed ID: 14754896 [TBL] [Abstract][Full Text] [Related]
17. Combinatorial BTK and MALT1 inhibition augments killing of CD79 mutant diffuse large B cell lymphoma. Nagel D; Bognar M; Eitelhuber AC; Kutzner K; Vincendeau M; Krappmann D Oncotarget; 2015 Dec; 6(39):42232-42. PubMed ID: 26540570 [TBL] [Abstract][Full Text] [Related]